Mizuho Downgrades Acadia Pharmaceuticals (ACAD) to Neutral, ‘Disappointing ADVANCE-2 Data’

Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Mizuho++Downgrades+Acadia+Pharmaceuticals+%28ACAD%29+to+Neutral%2C+%27Disappointing+ADVANCE-2+Data%27/22915767.html for the full story.